$INTC
Intel Corp Stock $intc

$intc Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000005086323000103 Filed on October 27, 2023

Income Statement

Concept	2023 Q4
Revenue	$15.41B
YoY Change	0.44%
Cost Of Revenue	$8.359B
YoY Change	-5.04%
Gross Profit	$7.047B
YoY Change	7.83%
Gross Profit Margin	45.74%
Selling, General & Admin	$1.617B
YoY Change	-7.28%
% of Gross Profit	22.95%
Research & Development	$3.987B
YoY Change	-7.32%
% of Gross Profit	56.58%
Depreciation & Amortization	$2.513B
YoY Change	-22.72%
% of Gross Profit	35.66%
Operating Expenses	$5.604B
YoY Change	-16.48%
Operating Profit	$1.443B
YoY Change	-924.57%
Interest Expense	$175.0M
YoY Change	53.51%
% of Operating Profit	12.13%
Other Income/Expense, Net	$28.00M
YoY Change	-79.71%
Pretax Income	$2.788B
YoY Change	-1582.98%
Income Tax	$128.0M
% Of Pretax Income	4.59%
Net Earnings	$2.669B
YoY Change	161.92%
Net Earnings / Revenue	17.32%
Basic Earnings Per Share
Diluted Earnings Per Share	$0.62
COMMON SHARES
Basic Shares Outstanding	4.216B shares
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$25.03B
YoY Change	10.97%
Cash & Equivalents	$7.079B
Short-Term Investments	$17.96B
Other Short-Term Assets	$3.706B
YoY Change	-41.62%
Inventory	$11.13B
Prepaid Expenses
Receivables	$3.402B
Other Receivables	$0.00
Total Short-Term Assets	$43.27B
YoY Change	-12.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$96.65B
YoY Change	27.56%
Goodwill	$27.59B
YoY Change	0.0%
Intangibles	$4.589B
YoY Change	-26.79%
Long-Term Investments	$5.000M
YoY Change	-54.55%
Other Assets	$13.65B
YoY Change	34.67%
Total Long-Term Assets	$148.3B
YoY Change	18.1%
TOTAL ASSETS
Total Short-Term Assets	$43.27B
Total Long-Term Assets	$148.3B
Total Assets	$191.6B
YoY Change	9.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.578B
YoY Change	20.26%
Accrued Expenses	$16.08B
YoY Change	-12.59%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$2.288B
YoY Change	0.22%
Total Short-Term Liabilities	$28.05B
YoY Change	0.86%
LONG-TERM LIABILITIES
Long-Term Debt	$46.98B
YoY Change	26.15%
Other Long-Term Liabilities	$6.576B
YoY Change	14.17%
Total Long-Term Liabilities	$53.55B
YoY Change	24.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$28.05B
Total Long-Term Liabilities	$53.55B
Total Liabilities	$81.61B
YoY Change	15.24%
SHAREHOLDERS EQUITY
Retained Earnings	$69.16B
YoY Change	-2.63%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$105.6B
YoY Change
Total Liabilities & Shareholders Equity	$191.6B
YoY Change	9.57%

Cashflow Statement

Concept	2023 Q4
OPERATING ACTIVITIES
Net Income	$2.669B
YoY Change	161.92%
Depreciation, Depletion And Amortization	$2.513B
YoY Change	-22.72%
Cash From Operating Activities	$4.624B
YoY Change	348.93%
INVESTING ACTIVITIES
Capital Expenditures	$6.696B
YoY Change	-191.74%
Acquisitions
YoY Change
Other Investing Activities	$1.378B
YoY Change	-49.43%
Cash From Investing Activities	-$5.318B
YoY Change	16.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	152.0M
YoY Change	-95.87%
NET CHANGE
Cash From Operating Activities	4.624B
Cash From Investing Activities	-5.318B
Cash From Financing Activities	152.0M
Net Change In Cash	-542.0M
YoY Change	-489.93%
FREE CASH FLOW
Cash From Operating Activities	$4.624B
Capital Expenditures	$6.696B
Free Cash Flow	-$2.072B
YoY Change	-124.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	1536000000	usd
CY2022Q4	intc	Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge	0	usd
	intc	Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge	0	usd
	intc	Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge	0	usd
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	97122000000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	93386000000	usd
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4216000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4137000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4216000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4137000000	shares
CY2023Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	93352000000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	80860000000	usd
CY2023Q3	intc	Equity Investments EquityInvestments	5700000000	usd
CY2022Q4	intc	Equity Investments EquityInvestments	5912000000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	27591000000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	27591000000	usd
CY2023Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4970000000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6018000000	usd
CY2023Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13413000000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11315000000	usd
CY2023Q3	us-gaap	Assets Assets	188837000000	usd
CY2022Q4	us-gaap	Assets Assets	182103000000	usd
CY2023Q3	us-gaap	Debt Current DebtCurrent	2288000000	usd
CY2022Q4	us-gaap	Debt Current DebtCurrent	4367000000	usd
CY2023Q3	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2112000000	usd
CY2022Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2251000000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	12430000000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	11858000000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	28614000000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	32155000000	usd
CY2023Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	46591000000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	37684000000	usd
CY2023Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7946000000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8978000000	usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	35653000000	usd
CY2022Q4	us-gaap	Common Stocks Including Additional Paid In Capital CommonStocksIncludingAdditionalPaidInCapital	31580000000	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-861000000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-562000000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	67021000000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	70405000000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	101813000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	101423000000	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	3873000000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	1863000000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	105686000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	103286000000	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	188837000000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	182103000000	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1290000000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1758000000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1082000000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1171000000	usd
	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-2676000000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	574000000	usd
	us-gaap	Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities	7832000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6847000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19054000000	usd
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	375000000	usd
	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	4880000000	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	0	usd
	us-gaap	Proceeds From Divestiture Of Businesses ProceedsFromDivestitureOfBusinesses	6579000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	2764000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6990000000	usd
	us-gaap	Repayments Of Commercial Paper RepaymentsOfCommercialPaper	3944000000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	96000000	usd
	intc	Proceeds From Partner Contributions ProceedsFromPartnerContributions	1106000000	usd
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2423000000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	11391000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	423000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	968000000	usd
	us-gaap	Interest Paid Net InterestPaidNet	315000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1649000000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3960000000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	104471000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	310000000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-317000000	usd
CY2023Q3	intc	Noncontrolling Interest Increase From Sale Of Parent Equity Interest And Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSaleOfParentEquityInterestAndSubsidiaryEquityIssuance	759000000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	372000000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	772000000	usd
CY2023Q3	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	156000000	usd
CY2023Q3	us-gaap	Dividends Common Stock DividendsCommonStock	525000000	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	105686000000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	1019000000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-426000000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	399000000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	793000000	usd
CY2022Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	106000000	usd
CY2022Q4	us-gaap	Dividends Common Stock DividendsCommonStock	3012000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	99885000000	usd
	us-gaap	Profit Loss ProfitLoss	-985000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-299000000	usd
	intc	Noncontrolling Interest Increase From Sale Of Parent Equity Interest And Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSaleOfParentEquityInterestAndSubsidiaryEquityIssuance	3166000000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	1037000000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2433000000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	95391000000	usd
	us-gaap	Profit Loss ProfitLoss	8678000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1171000000	usd
	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	1000000000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2392000000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	407000000	usd
	us-gaap	Dividends Common Stock DividendsCommonStock	5998000000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	99885000000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8000000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-175000000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2492000000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	3466000000	usd
CY2022Q4	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	559000000	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	310000000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	1019000000	usd
	us-gaap	Profit Loss ProfitLoss	-985000000	usd
	us-gaap	Profit Loss ProfitLoss	8678000000	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	13000000	usd
CY2022Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-5000000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	297000000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	1019000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-980000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	8678000000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4202000000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4118000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4180000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4104000000	shares
CY2023Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	27000000	shares
CY2022Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	7000000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	19000000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4229000000	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4125000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4180000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4123000000	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.25
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.11
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.25
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.10
	us-gaap	Accounts Receivable Sale AccountsReceivableSale	1500000000	usd
CY2023Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1278000000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1517000000	usd
CY2023Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	6266000000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7565000000	usd
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	3922000000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	4142000000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	11466000000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	13224000000	usd
CY2023Q3	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	2600000000	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	2400000000	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	332000000	usd
CY2022Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	170000000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	979000000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	315000000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	204000000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	114000000	usd
	us-gaap	Interest Expense InterestExpense	611000000	usd
	us-gaap	Interest Expense InterestExpense	347000000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	19000000	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	82000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	144000000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1048000000	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	147000000	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	138000000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	512000000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1016000000	usd
CY2023Q3	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	395000000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1100000000	usd
CY2022Q4	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	220000000	usd
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	516000000	usd
CY2023Q3	us-gaap	Severance Costs1 SeveranceCosts1	59000000	usd
CY2022Q4	us-gaap	Severance Costs1 SeveranceCosts1	607000000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	191000000	usd
	us-gaap	Severance Costs1 SeveranceCosts1	650000000	usd
CY2023Q3	intc	Litigation Charges And Other LitigationChargesAndOther	757000000	usd
CY2022Q4	intc	Litigation Charges And Other LitigationChargesAndOther	4000000	usd
	intc	Litigation Charges And Other LitigationChargesAndOther	854000000	usd
	intc	Litigation Charges And Other LitigationChargesAndOther	-1199000000	usd
CY2023Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2022Q4	us-gaap	Asset Impairment Charges AssetImpairmentCharges	53000000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	35000000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	89000000	usd
CY2023Q3	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	816000000	usd
CY2022Q4	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	664000000	usd
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	1080000000	usd
	us-gaap	Restructuring Settlement And Impairment Provisions RestructuringSettlementAndImpairmentProvisions	-460000000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-52000000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-188000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2026000000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8564000000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-362000000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1207000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1041000000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-114000000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	6.962
CY2022Q4	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	6.420
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.514
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.013
CY2023Q3	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	329000000	usd
	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	-336000000	usd
CY2022Q4	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	861000000	usd
	us-gaap	Debt Securities Realized Gain Loss DebtSecuritiesRealizedGainLoss	1800000000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	6100000000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	10200000000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue	11487000000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	2249000000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	6220000000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	417000000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	1814000000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	22187000000	usd
CY2023Q3	us-gaap	Marketable Securities MarketableSecurities	1117000000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	1341000000	usd
CY2023Q3	us-gaap	Other Investments And Securities At Cost OtherInvestmentsAndSecuritiesAtCost	4578000000	usd
CY2022Q4	us-gaap	Other Investments And Securities At Cost OtherInvestmentsAndSecuritiesAtCost	4561000000	usd
CY2023Q3	us-gaap	Equity Method Investments EquityMethodInvestments	5000000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	10000000	usd
CY2023Q3	intc	Equity Investments EquityInvestments	5700000000	usd
CY2022Q4	intc	Equity Investments EquityInvestments	5912000000	usd
	intc	Marketable Securities Subject To Limitations On Sales Percentage MarketableSecuritiesSubjectToLimitationsOnSalesPercentage	0.90
	intc	Marketable Securities Trading Volume Restrictions Shares Owned Threshold Percentage MarketableSecuritiesTradingVolumeRestrictionsSharesOwnedThresholdPercentage	0.01
CY2023Q3	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-267000000	usd
CY2022Q4	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-244000000	usd
	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-164000000	usd
	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	-883000000	usd
CY2023Q3	intc	Observablepriceadjustmentsonnonmarketable Observablepriceadjustmentsonnonmarketable	7000000	usd
CY2022Q4	intc	Observablepriceadjustmentsonnonmarketable Observablepriceadjustmentsonnonmarketable	67000000	usd
	intc	Observablepriceadjustmentsonnonmarketable Observablepriceadjustmentsonnonmarketable	17000000	usd
	intc	Observablepriceadjustmentsonnonmarketable Observablepriceadjustmentsonnonmarketable	273000000	usd
CY2023Q3	us-gaap	Impairment Of Investments ImpairmentOfInvestments	53000000	usd
CY2022Q4	us-gaap	Impairment Of Investments ImpairmentOfInvestments	45000000	usd
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	127000000	usd
	us-gaap	Impairment Of Investments ImpairmentOfInvestments	112000000	usd
CY2023Q3	intc	Other Net Equity Investments OtherNetEquityInvestments	122000000	usd
CY2022Q4	intc	Other Net Equity Investments OtherNetEquityInvestments	71000000	usd
	intc	Other Net Equity Investments OtherNetEquityInvestments	228000000	usd
	intc	Other Net Equity Investments OtherNetEquityInvestments	4804000000	usd
CY2023Q3	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-191000000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-151000000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	-46000000	usd
	us-gaap	Equity Securities Fv Ni Gain Loss EquitySecuritiesFvNiGainLoss	4082000000	usd
CY2023Q3	intc	Equity Securities Fvni Gain Loss Net EquitySecuritiesFVNIGainLossNet	-205000000	usd
CY2022Q4	intc	Equity Securities Fvni Gain Loss Net EquitySecuritiesFVNIGainLossNet	-154000000	usd
	intc	Equity Securities Fvni Gain Loss Net EquitySecuritiesFVNIGainLossNet	-64000000	usd
	intc	Equity Securities Fvni Gain Loss Net EquitySecuritiesFVNIGainLossNet	-490000000	usd
CY2023Q3	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	12000000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	1000000	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	-15000000	usd
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	15000000	usd
CY2023Q3	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-193000000	usd
CY2022Q4	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-153000000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-79000000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-475000000	usd
CY2023Q3	us-gaap	Repayments Of Commercial Paper RepaymentsOfCommercialPaper	3900000000	usd
CY2022Q4	us-gaap	Commercial Paper CommercialPaper	3900000000	usd
CY2023Q3	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	51314000000	usd
CY2022Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	49708000000	usd
CY2023Q3	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1011000000	usd
CY2023Q3	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2023Q3	us-gaap	Derivative Assets DerivativeAssets	1011000000	usd
CY2023Q3	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	538000000	usd
CY2023Q3	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	473000000	usd
CY2023Q3	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2023Q3	us-gaap	Securities Purchased Under Agreements To Resell Gross SecuritiesPurchasedUnderAgreementsToResellGross	2334000000	usd
CY2023Q3	us-gaap	Securities Purchased Under Agreements To Resell Liability SecuritiesPurchasedUnderAgreementsToResellLiability	0	usd
CY2023Q3	us-gaap	Securities Purchased Under Agreements To Resell SecuritiesPurchasedUnderAgreementsToResell	2334000000	usd
CY2023Q3	us-gaap	Securities Purchased Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesPurchasedUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	usd
CY2023Q3	us-gaap	Securities Purchased Under Agreements To Resell Collateral Obligation To Return Securities SecuritiesPurchasedUnderAgreementsToResellCollateralObligationToReturnSecurities	2334000000	usd
CY2023Q3	us-gaap	Securities Purchased Under Agreements To Resell Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election SecuritiesPurchasedUnderAgreementsToResellOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2023Q3	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Gross DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedGross	3345000000	usd
CY2023Q3	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability	0	usd
CY2023Q3	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowed	3345000000	usd
CY2023Q3	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Not Offset Policy Election Deduction DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedNotOffsetPolicyElectionDeduction	538000000	usd
CY2023Q3	intc	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Collateral Obligation To Return Cash Or Non Cash DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedCollateralObligationToReturnCashOrNonCash	2807000000	usd
CY2023Q3	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2023Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1724000000	usd
CY2023Q3	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	1724000000	usd
CY2023Q3	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	538000000	usd
CY2023Q3	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	1085000000	usd
CY2023Q3	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	101000000	usd
CY2023Q3	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1724000000	usd
CY2023Q3	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	1724000000	usd
CY2023Q3	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	538000000	usd
CY2023Q3	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	1085000000	usd
CY2023Q3	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	101000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1231000000	usd
CY2022Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	1231000000	usd
CY2022Q4	us-gaap	Derivative Asset Not Offset Policy Election Deduction DerivativeAssetNotOffsetPolicyElectionDeduction	546000000	usd
CY2022Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	682000000	usd
CY2022Q4	us-gaap	Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	3000000	usd
CY2022Q4	us-gaap	Securities Purchased Under Agreements To Resell Gross SecuritiesPurchasedUnderAgreementsToResellGross	1701000000	usd
CY2022Q4	us-gaap	Securities Purchased Under Agreements To Resell Liability SecuritiesPurchasedUnderAgreementsToResellLiability	0	usd
CY2022Q4	us-gaap	Securities Purchased Under Agreements To Resell SecuritiesPurchasedUnderAgreementsToResell	1701000000	usd
CY2022Q4	us-gaap	Securities Purchased Under Agreements To Resell Not Offset Policy Election Deduction SecuritiesPurchasedUnderAgreementsToResellNotOffsetPolicyElectionDeduction	0	usd
CY2022Q4	us-gaap	Securities Purchased Under Agreements To Resell Collateral Obligation To Return Securities SecuritiesPurchasedUnderAgreementsToResellCollateralObligationToReturnSecurities	1701000000	usd
CY2022Q4	us-gaap	Securities Purchased Under Agreements To Resell Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election SecuritiesPurchasedUnderAgreementsToResellOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	0	usd
CY2022Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Gross DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedGross	2932000000	usd
CY2022Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Liability DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedLiability	0	usd
CY2022Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowed	2932000000	usd
CY2022Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Not Offset Policy Election Deduction DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedNotOffsetPolicyElectionDeduction	546000000	usd
CY2022Q4	intc	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Collateral Obligation To Return Cash Or Non Cash DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedCollateralObligationToReturnCashOrNonCash	2383000000	usd
CY2022Q4	us-gaap	Derivative Asset Securities Purchased Under Agreements To Resell Securities Borrowed Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeAssetSecuritiesPurchasedUnderAgreementsToResellSecuritiesBorrowedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	3000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1337000000	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1337000000	usd
CY2022Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	546000000	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	712000000	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	79000000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1337000000	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1337000000	usd
CY2022Q4	us-gaap	Derivative Liability Not Offset Policy Election Deduction DerivativeLiabilityNotOffsetPolicyElectionDeduction	546000000	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	712000000	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election DerivativeLiabilityFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection	79000000	usd
CY2023Q3	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	168000000	usd
CY2022Q4	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	589000000	usd
	us-gaap	Change In Unrealized Gain Loss On Hedged Item In Fair Value Hedge1 ChangeInUnrealizedGainLossOnHedgedItemInFairValueHedge1	189000000	usd
CY2023Q3	intc	Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge NetChangeInUnrealizedGainLossRecognizedInIncomeStatementOnFairValueHedgingInstrumentsAndOnHedgedItemInFairValueHedge	0	usd
	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	<div style="margin-bottom:9pt;margin-top:15pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:10.238%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.562%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#0068b5;border-bottom:1pt solid #0068b5;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Note 13 : </span></td><td colspan="3" style="border-bottom:1pt solid #0068b5;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:14pt;font-weight:400;line-height:120%">Contingencies</span></td></tr></table></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We are regularly party to various ongoing claims, litigation, and other proceedings, including those noted in this section. We have accrued a charge of $2.2 billion related to litigation involving VLSI and a charge of $401 million related to an EC-imposed fine, both as described below. Excluding the VLSI claims, management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends; however, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings, excessive verdicts, or other events could occur. Unfavorable resolutions could include substantial monetary damages, fines, or penalties. Certain of these outstanding matters include speculative, substantial, or indeterminate monetary awards. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Unless specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time. </span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">European Commission Competition Matter </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In 2009, the EC found that we had used unfair business practices to persuade customers to buy microprocessors in violation of Article 82 of the EC Treaty (later renumbered Article 102) and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 by offering alleged “conditional rebates and payments” that required customers to purchase all or most of their x86 microprocessors from us and by making alleged “payments to prevent sales of specific rival products.” The EC ordered us to end the alleged infringement referred to in its decision and imposed a €1.1 billion fine, which we paid in the third quarter of 2009. </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We appealed the EC decision to the European Court of Justice in 2014, after the General Court (then called the Court of First Instance) rejected our appeal of the EC decision in its entirety. In September 2017, the Court of Justice sent the case back to the General Court to examine whether the rebates at issue were capable of restricting competition. </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In January 2022, the General Court annulled the EC’s 2009 findings against us regarding rebates, as well as the €1.1 billion fine imposed on Intel, which was returned to us in February 2022. The General Court’s January 2022 decision did not annul the EC’s 2009 finding that we made payments to prevent sales of specific rival products.</span></div><div style="margin-bottom:6pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In April 2022, the EC appealed the General Court’s decision to the Court of Justice. In addition, in September 2023 the EC imposed a €376 million ($401 million) fine against us based on its finding that we made payments to prevent sales of specific rival products. We plan to appeal the EC’s decision. We have accrued a charge for the fine and are unable to make a reasonable estimate of the potential loss or range of losses in excess of this amount given the procedural posture and the nature of these proceedings. </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In a related matter, in April 2022 we filed applications with the General Court seeking an order requiring the EC to pay us approximately €593 million in default interest on the original €1.1 billion fine that was held by the EC for 12 years, which applications have been stayed pending the EC’s appeal of the General Court’s January 2022 decision.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation Related to Security Vulnerabilities </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In June 2017, a Google research team notified Intel and other companies that it had identified security vulnerabilities, now commonly referred to as “Spectre” and “Meltdown,” that affect many types of microprocessors, including our products. As is standard when findings like these are presented, we worked together with other companies in the industry to verify the research and develop and validate software and firmware updates for impacted technologies. In January 2018, information on the security vulnerabilities was publicly reported, before software and firmware updates to address the vulnerabilities were made widely available. </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of October 25, 2023, consumer class action lawsuits against us were pending in the US, Canada, and Argentina. The plaintiffs, who purport to represent various classes of purchasers of our products, generally claim to have been harmed by our actions and/or omissions in connection with the security vulnerabilities and assert a variety of common law and statutory claims seeking monetary damages and equitable relief. In the US, class action suits filed in various jurisdictions were consolidated for all pretrial proceedings in the US District Court for the District of Oregon, which entered final judgment in favor of Intel in July 2022 based on plaintiffs’ failure to plead a viable claim. Plaintiffs have appealed that decision to the Ninth Circuit Court of Appeals. In Canada, an initial status conference has not yet been scheduled in one case pending in the Superior Court of Justice of Ontario, and a stay of a second case pending in the Superior Court of Justice of Quebec is in effect.</span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In Argentina, Intel Argentina was served with, and responded to, a class action complaint in June 2022. The Argentinian court dismissed plaintiffs’ claims for lack of standing in May 2023, and plaintiffs have appealed. Additional lawsuits and claims may be asserted seeking monetary damages or other related relief. We dispute the pending claims described above and intend to defend those lawsuits vigorously. Given the procedural posture and the nature of those cases, including that the pending proceedings are in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class or classes being certified or the ultimate size of any class or classes if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from those matters. </span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation Related to 7nm Product Delay Announcement </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Multiple securities class action lawsuits were filed in the US District Court for the Northern District of California against us and certain officers following our July 2020 announcement of 7nm product delays. The court consolidated the lawsuits and appointed lead plaintiffs in October 2020, and in January 2021 plaintiffs filed a consolidated complaint. Plaintiffs purport to represent all persons who purchased or otherwise acquired our common stock from October 25, 2019 through October 23, 2020, and they generally allege that defendants violated the federal securities laws by making false or misleading statements about the timeline for 7nm products. In March 2023, the court granted the defendants’ motion to dismiss the consolidated complaint, and in April 2023 entered judgment. Plaintiffs have appealed. Given the procedural posture and the nature of the case, including that it is in the early stages, that alleged damages have not been specified, that uncertainty exists as to the likelihood of a class being certified or the ultimate size of any class if certified, and that there are significant factual and legal issues to be resolved, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from the matter. In July 2021, we introduced a new process node naming structure, and the 7nm process is now called Intel 4.</span></div><div style="margin-bottom:9pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Litigation Related to Patent and IP Claims</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have had IP infringement lawsuits filed against us, including but not limited to those discussed below. Most involve claims that certain of our products, services, and technologies infringe others' IP rights. Adverse results in these lawsuits may include awards of substantial fines and penalties, costly royalty or licensing agreements, or orders preventing us from offering certain features, functionalities, products, or services. As a result, we may have to change our business practices, and develop non-infringing products or technologies, which could result in a loss of revenue for us and otherwise harm our business. In addition, certain agreements with our customers require us to indemnify them against certain IP infringement claims, which can increase our costs as a result of defending such claims, and may require that we pay significant damages, accept product returns, or supply our customers with non-infringing products if there were an adverse ruling in any such claims. In addition, our customers and partners may discontinue the use of our products, services, and technologies, as a result of injunctions or otherwise, which could result in loss of revenue and adversely affect our business.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">VLSI Technology LLC v. Intel </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In October 2017, VLSI Technology LLC (VLSI) filed a complaint against us in the US District Court for the Northern District of California alleging that various Intel FPGA and processor products infringe eight patents that VLSI acquired from NXP Semiconductors, N.V. (NXP). Four patents remain at issue in the case, and VLSI estimates its damages to be approximately $890 million, and seeks enhanced damages, future royalties, attorneys’ fees, costs, and interest. We filed Inter Partes Review (IPR) petitions with the Patent Trial and Appeal Board (PTAB) in 2018 challenging patentability, and the parties stipulated to stay the district court action pending the PTAB’s review. The PTAB subsequently found all claims of two patents, and some claims of two other patents, to be unpatentable. The district court lifted the stay in September 2021, and scheduled trial for March 2024 on the claims that were found patentable by the PTAB.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In April 2019, VLSI filed three infringement suits against us in the US District Court for the Western District of Texas accusing various of our processors of infringement of eight additional patents it had acquired from NXP:</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">▪</span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.81pt">The first Texas case went to trial in February 2021, and the jury awarded VLSI $1.5 billion for literal infringement of one patent and $675 million for infringement of another patent under the doctrine of equivalents. In April 2022, the court entered final judgment, awarding VLSI $2.2 billion in damages and approximately $162.3 million in pre-judgment and post-judgment interest. We have appealed the judgment to the Federal Circuit Court of Appeals, including the court's rejection of Intel's claim to have a license from Fortress Investment Group’s acquisition of Finjan. The Federal Circuit Court heard oral argument in October 2023. In December 2021 and January 2022 the PTAB instituted IPRs on the claims found to have been infringed in the first Texas case, and in May and June 2023 found all of those claims unpatentable; VLSI has appealed the PTAB’s decisions, and has asked to stay those appeals while the PTAB decides certain issues unrelated to the merits of the IPRs. Intel has agreed to the stay.</span></div><div style="margin-bottom:3pt;padding-left:9pt;text-indent:-9pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">▪</span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.81pt">The second Texas case went to trial in April 2021, and the jury found that we do not infringe the asserted patents. VLSI had sought approximately $3.0 billion for alleged infringement, plus enhanced damages for willful infringement. The court has not yet entered final judgment. </span></div><div style="margin-bottom:9pt;padding-left:9pt;text-indent:-9pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">▪</span><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;padding-left:5.81pt">The third Texas case went to trial in November 2022, with VLSI asserting one remaining patent. The jury found the patent valid and infringed, and awarded VLSI approximately $949 million in damages, plus interest and a running royalty. The court has not yet entered final judgment. In February 2023, we filed motions for a new trial and for judgment as a matter of law notwithstanding the verdict on various grounds. Further appeals are possible. </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2019, VLSI filed a case in Shenzhen Intermediate People’s Court against Intel, Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. VLSI asserts one patent against certain Intel Core processors. Defendants filed an invalidation petition in October 2019 with the China National Intellectual Property Administration (CNIPA) which held a hearing in September 2021. The Shenzhen court held trial proceedings in July 2021, and September 2023. VLSI seeks an injunction as well as RMB 1.3 million in costs and expenses, but no damages. In September 2023, the CNIPA invalidated every claim of the asserted patent.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In May 2019, VLSI filed a case in Shanghai Intellectual Property Court against Intel (China) Co., Ltd., Intel Trading (Shanghai) Co., Ltd., and Intel Products (Chengdu) Co., Ltd. asserting one patent against certain Intel core processors. The court held a trial hearing in December 2020, where VLSI requested expenses (RMB 300 thousand) and an injunction. In December 2022, we filed a petition to invalidate the patent at issue. The court held a second trial hearing in May 2022, and in October 2023, issued a decision finding no infringement and dismissing all claims.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We have accrued a charge of approximately $2.2 billion related to the VLSI litigation. While we dispute VLSI’s claims and intend to vigorously defend against them, we are unable to make a reasonable estimate of losses in excess of recorded amounts given recent developments and future proceedings.</span></div><div style="margin-bottom:6pt"><span style="color:#0068b5;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R2 Semiconductor Patent Litigation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In November 2022, R2 Semiconductor, Inc. (R2) filed a lawsuit in the High Court of Justice in the UK against Intel Corporation (UK) Limited and Intel Corporation, and a lawsuit in the Dusseldorf Regional Court in Germany against Intel Deutschland GmbH and certain Intel customers. R2 asserts one European patent is infringed by Intel’s Ice Lake, Tiger Lake, Alder Lake and Ice Lake Server (Xeon) processors, and customer servers and laptops that contain those processors. R2 seeks an injunction in both actions prohibiting the sale and requiring the recall of the alleged infringing products. Intel is indemnifying its customers in the German lawsuit.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Intel disputes R2’s claims and intends to defend the lawsuits vigorously. In December 2022, Intel responded in the UK action that the asserted patent is not infringed and that the patent is invalid. In April 2023, defendants filed statements of defense in the German action that the asserted patent is not infringed and that an injunction would be a disproportionate remedy. In May 2023, defendants also filed a nullity action in the German Federal Patent Court on the ground that the asserted patent is invalid.</span></div><div style="margin-bottom:9pt"><span style="color:#262626;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Trial is scheduled for December 2023 in the Dusseldorf Regional Court, and for April 2024 in the UK High Court of Justice. If defendants lose at trial in Germany, the Dusseldorf Regional Court could impose an injunction and recall order prohibiting sales of the accused products in Germany which could take effect immediately and remain in place unless overturned on appeal, or unless the patent is invalidated by the German Federal Patent Court. Given the procedural posture and the nature of these cases, including that there are significant factual and legal issues to be resolved and that uncertainty exists as to the scope of an injunction, if any, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, that might arise from these lawsuits.</span></div>
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
intc-20230930_lab.xml	Edgar Link	unprocessable
intc-20230930_cal.xml	Edgar Link	unprocessable
0000050863-23-000103-index-headers.html	Edgar Link	pending
0000050863-23-000103-index.html	Edgar Link	pending
0000050863-23-000103.txt	Edgar Link	pending
0000050863-23-000103-xbrl.zip	Edgar Link	pending
a09302023ex31.htm	Edgar Link	pending
a09302023ex311.htm	Edgar Link	pending
a09302023ex312.htm	Edgar Link	pending
a09302023ex321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
intc-20230930.htm	Edgar Link	pending
intc-20230930.xsd	Edgar Link	pending
intc-20230930_g1.jpg	Edgar Link	pending
intc-20230930_g10.jpg	Edgar Link	pending
intc-20230930_g11.jpg	Edgar Link	pending
intc-20230930_g12.jpg	Edgar Link	pending
intc-20230930_g13.jpg	Edgar Link	pending
intc-20230930_g14.jpg	Edgar Link	pending
intc-20230930_g15.jpg	Edgar Link	pending
intc-20230930_g16.jpg	Edgar Link	pending
intc-20230930_g17.jpg	Edgar Link	pending
intc-20230930_g18.jpg	Edgar Link	pending
intc-20230930_g19.jpg	Edgar Link	pending
intc-20230930_g2.jpg	Edgar Link	pending
intc-20230930_g20.jpg	Edgar Link	pending
intc-20230930_g21.jpg	Edgar Link	pending
intc-20230930_g22.jpg	Edgar Link	pending
intc-20230930_g23.jpg	Edgar Link	pending
intc-20230930_g24.jpg	Edgar Link	pending
intc-20230930_g25.jpg	Edgar Link	pending
intc-20230930_g26.jpg	Edgar Link	pending
intc-20230930_g27.jpg	Edgar Link	pending
intc-20230930_g3.jpg	Edgar Link	pending
intc-20230930_g4.jpg	Edgar Link	pending
intc-20230930_g5.jpg	Edgar Link	pending
intc-20230930_g6.jpg	Edgar Link	pending
intc-20230930_g7.jpg	Edgar Link	pending
intc-20230930_g8.jpg	Edgar Link	pending
intc-20230930_g9.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
intc-20230930_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
intc-20230930_pre.xml	Edgar Link	unprocessable
intc-20230930_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INTC
Intel Corp Stock $intc

2023 Q4 Form 10-Q Financial Statement

#000005086323000103 Filed on October 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INTC Intel Corp Stock $intc

2023 Q4 Form 10-Q Financial Statement

#000005086323000103 Filed on October 27, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INTC
Intel Corp Stock $intc